Analysis of outcomes after non-contour-based dose painting of dominant intra-epithelial lesion in intra-operative low-dose rate brachytherapy
Purpose: To compare the outcomes of patients with intermediate risk prostate cancer (IR-PCa) treated with low-dose rate I-125 seed brachytherapy (LDR-BT) and targeted dose painting of a histologic dominant intra-epithelial lesion (DIL) to those without a DIL. Methods: 455 patients with IR-PCa were t...
Main Authors: | Kevin Martell, Soumyajit Roy, Tyler Meyer, Jordan Stosky, Will Jiang, Kundan Thind, Michael Roumeliotis, John Bosch, Steve Angyalfi, Harvey Quon, Siraj Husain |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844020309361 |
Similar Items
-
Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma
by: Rutvij A. Khanolkar, et al.
Published: (2021-09-01) -
Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
by: Kevin Martell, et al.
Published: (2017-04-01) -
Development of booklet on male sexual dysfunction, its measures and assessing its impact on knowledge of patients with urological cancers
by: Jackson Yovin Chellayadhas, et al.
Published: (2016-01-01) -
Laparoendoscopic single-site surgery and cancer
by: Evangelos N Liatsikos, et al.
Published: (2012-01-01) -
Current Status of Urological Surgery Clinical Trials in the Middle East and Its Analysis in Comparison to Global
by: Fatih Özdener, et al.
Published: (2019-12-01)